Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Hormonal
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local

abstract

  • The data from the current study document a 0.4% rate of distant metastasis within 5 years of BC diagnosis among patients with lymph node-negative ER+/HER2- BC with an RS <18. Patients aged <40 years at the time of BC diagnosis were observed to have a higher rate of distant metastases. Analysis of data from other studies is necessary to validate this observation further. Cancer 2017;131-137. © 2016 American Cancer Society.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5161549

Digital Object Identifier (DOI)

  • 10.1002/cncr.30271

PubMed ID

  • 27526056

Additional Document Info

start page

  • 131

end page

  • 137

volume

  • 123

number

  • 1